More on MIRA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (9/2/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Mira Pharma (NQ:MIRA)
Delayed: 0.94 -0.02 (2.08%)
Prev. Close $0.96  
Open$0.96 
52 Wk High$0.04 
52 Wk Low$0.00 
Day High$0.98 
Day Low$0.94 
P/E N/A  
EPS$0.00 
Volume123,120 


Jun 9, 2026 05:00 PM Form 3 MIRA PHARMACEUTICALS, For: Jun 02 Filed by: Mushak Andriy
Jun 8, 2026 05:01 PM Form 8-K MIRA PHARMACEUTICALS, For: Jun 02
Jun 4, 2026 08:02 AM MIRA Pharmaceuticals secures global rights to drug candidates
Jun 4, 2026 08:01 AM Form 8-K MIRA PHARMACEUTICALS, For: Jun 03
Jun 4, 2026 08:00 AM MIRA Pharmaceuticals Secures Worldwide Exclusive Rights to MIRA-55 and SKNY-1
May 27, 2026 08:01 AM Form 8-K MIRA PHARMACEUTICALS, For: May 21
May 27, 2026 08:00 AM MIRA Pharmaceuticals expands Ketamir-2 licensing to worldwide rights
May 27, 2026 08:00 AM MIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPN
May 14, 2026 03:04 PM Form 10-Q MIRA PHARMACEUTICALS, For: Mar 31
May 14, 2026 08:01 AM MIRA Pharmaceuticals reports positive Phase 1 results for Ketamir-2
View All Articles

Entities mentioned with MIRA

View All Entities